Loading organizations...
Essex Capital Group functions as a corporate finance advisory firm, delivering strategic financial solutions to businesses. Specializing in capital structures, the firm provides expertise in sourcing, negotiating, and structuring diverse financing arrangements. It crafts tailored capital solutions designed to achieve unique corporate objectives for its clients.
Based in Tampa, Florida, Essex Capital Group was founded by a team bringing over a century of collective corporate finance experience. This extensive background and deep understanding of capital markets drove its establishment. The group formed from the insight that middle-market enterprises require sophisticated financial advisory from seasoned professionals.
The firm serves a broad clientele, primarily small and middle-market privately held companies seeking expert financial guidance. Essex Capital Group's vision is to empower these businesses by ensuring access to flexible, specialized financing. It strives to be a trusted partner, providing essential capital for clients to meet their strategic growth and operational ambitions.
Essex Capital Corporation has 3 tracked investments across 2 companies. The latest tracked deal is $20.6M Other Equity in Neos Therapeutics in February 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 25, 2015 | Neos Therapeutics | $20.6M Other Equity | — | Burrill Life Sciences Capital Fund III, CAC, Crabtree Partners, Delaware Street Capital, Presidio Partners |
| Jun 10, 2011 | Revance Therapeutics | $45.0M Other Equity | Jonathan Tunnicliffe | CNF Investments, PAC Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners, Vivo Ventures |
| Jun 1, 2011 | Revance Therapeutics | $45.0M Series D | Essex Woodlands, Novaquest Capital Management | Vivo Capital, CNF Investments, PAC Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners |
